Welcome
12 February 2012
Trial registration
Unique identification scheme
International databases
home
|
my details
|
ISRCTN Register
|
m
RCT
|
links
|
information
|
press
Find trials
ISRCTN Register
tips on searching
Registration
New application
Updating record
Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
International Standard Randomised Controlled Trial Number Register
Showing records:
6731
to
6740
of
10349
SEARCH FOR
RESULTS ORDER
DIRECTION
MAX RESULTS
Sponsor
ISRCTN
Date Assigned
Relevance
Ascending
Descending
10 per page
20 per page
50 per page
6731
A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South Africa
ISRCTN:
ISRCTN37373664
Sponsor:
World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
Date assigned:
25 November 2005
6732
A phase II, double-blind, randomised, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of three doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine (RIX4414 at 106.5 CCID50) administered to human immunodeficiency virus (HIV) infected infants at 6, 10 and 14 weeks of age in South Africa
ISRCTN:
ISRCTN11877362
Sponsor:
World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
Date assigned:
25 November 2005
6733
Study of safety and immunogenicity of Measles vaccine (Rouvax®) administered by transcutaneous route (France)
ISRCTN:
ISRCTN88861431
Sponsor:
World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
Date assigned:
25 November 2005
6734
A prospective randomised controlled trial of Vypro II and TiMesh in inguinal hernia repair using the total extraperitoneal endoscopic approach
ISRCTN:
ISRCTN96288558
Sponsor:
Spital Limmattal, Department of Surgery (Switzerland)
Date assigned:
24 November 2005
6735
Warning Time and Patient Centred Goals with Transdermal Oxybutynin
ISRCTN:
ISRCTN87161129
Sponsor:
King's College London (UK)
Date assigned:
24 November 2005
6736
Open, randomised phase III study assessing the toxicity and efficacy of platinum-based chemotherapy with vitamin supplementation in the treatment of lung cancer
ISRCTN:
ISRCTN87343655
Sponsor:
Royal Marsden Hospital (UK)
Date assigned:
24 November 2005
6737
Therapeutic vaccination for chronic hepatitis B virus infection in Africa
ISRCTN:
ISRCTN67270384
Sponsor:
University of Oxford (UK)
Date assigned:
23 November 2005
6738
Melioidosis ERadication THerapy/THailand
ISRCTN:
ISRCTN86140460
Sponsor:
Khon Kaen University (Thailand)
Date assigned:
23 November 2005
6739
The utility of pre-assessment standardised diagnosis in child and adolescent mental health services
ISRCTN:
ISRCTN31394658
Sponsor:
King's College London (UK)
Date assigned:
23 November 2005
6740
Randomised controlled trial to compare the effects of granulocyte-colony stimulating factor (G-CSF) and autologous bone marrow progenitor cells infusion on quality of life and left ventricular function in patients with heart failure secondary to ischaemic heart disease
ISRCTN:
ISRCTN68837678
Sponsor:
Barts and the London NHS Trust (UK)
Date assigned:
23 November 2005
RESULT PAGE
|<
<
670
671
672
673
674
675
676
677
678
>
>|
© 2012 ISRCTN unless otherwise stated.